Integrated expression profiles analysis reveals novel predictive biomarker in pancreatic ductal adenocarcinoma.
about
Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.DDX5/p68 associated lncRNA LOC284454 is differentially expressed in human cancers and modulates gene expression.Recurrence-associated gene signature optimizes recurrence-free survival prediction of colorectal cancer.Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer.Common Subcluster Mining in Microarray Data for Molecular Biomarker Discovery.IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
P2860
Integrated expression profiles analysis reveals novel predictive biomarker in pancreatic ductal adenocarcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Integrated expression profiles ...... creatic ductal adenocarcinoma.
@en
type
label
Integrated expression profiles ...... creatic ductal adenocarcinoma.
@en
prefLabel
Integrated expression profiles ...... creatic ductal adenocarcinoma.
@en
P2093
P2860
P356
P1433
P1476
Integrated expression profiles ...... creatic ductal adenocarcinoma.
@en
P2093
Baiyong Shen
Chenghong Peng
Hongzhe Li
Xiaxin Deng
Xinjing Wang
Xiongxiong Lu
P2860
P304
52571-52583
P356
10.18632/ONCOTARGET.16732
P407
P577
2017-03-31T00:00:00Z